Health Products

ACCESS HSTNI (2021-08-04)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesModel or catalog number
All lots. ACCESS HSTNI
Manufacturer
Beckman Coulter, Inc.
250 S. Kraemer Blvd.
Brea
92821
California
UNITED STATES
B52699

Introduction

Affected Products 

ACCESS HSTNI

Reason

LPN-000328, which was distributed in April 2020, notified customers of possible carryover with in-use, open (punctured) access hsTnI reagent packs, and the impact of carryover on patient samples that are tested from the same reagent pack as a sample with a high cardiac troponin (cTnI) concentration >270,000 pg/mL (ng/l).

A subsequent investigation has determined that, under certain conditions, carryover may also impact a different access hsTnI reagent pack.

Clinically significant carryover into a different pack can only occur if access hsTnI is the test performed immediately after a sample with a cTnI concentration >270,000 pg/mL (ng/l) and uses the same reagent pipettor.

Typically, cTnI concentrations >270,000 pg/mLpg/ml (ng/l) are not routinely observed in patients presenting to the emergency department with chest pain.

Although clinically significant carryover is rare, it can affect the results of all subsequent samples that are tested from the affected pack.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime